Lyra Therapeutics, Inc.
LYRA
$7.47
$0.131.77%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -6.15% | -21.79% | -21.40% | -23.51% | -22.52% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -41.06% | -11.36% | -13.13% | 45.48% | -16.69% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -8.38% | -21.20% | -20.97% | -21.59% | -22.37% |
|
|||||
Total Current Assets | -8.38% | -21.20% | -20.97% | -21.59% | -22.37% |
Net Property, Plant & Equipment | -4.41% | -4.27% | -4.44% | -3.61% | -53.14% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.05% | 0.00% | -25.53% |
Total Assets | -6.65% | -15.12% | -15.76% | -16.73% | -33.17% |
|
|||||
Total Accounts Payable | -6.21% | -38.51% | -48.56% | -53.89% | 74.79% |
Total Accrued Expenses | 7.39% | 6.44% | -33.97% | -47.55% | -39.40% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 7.28% | 2.96% | 2.95% | -6.23% | -5.22% |
Total Finance Division Other Current Liabilities | -17.32% | -18.49% | -4.43% | 38.59% | 198.79% |
Total Other Current Liabilities | -17.32% | -18.49% | -4.43% | 38.59% | 198.79% |
Total Current Liabilities | -2.68% | -9.19% | -15.53% | -22.42% | 2.95% |
|
|||||
Total Current Liabilities | -2.68% | -9.19% | -15.53% | -22.42% | 2.95% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -4.08% | -3.79% | -3.39% | -3.57% | -2.63% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 0.01% | -0.01% | 0.00% | 0.10% | -0.78% |
Total Liabilities | -2.85% | -4.22% | -5.82% | -8.60% | -0.65% |
|
|||||
Common Stock & APIC | 1.24% | 0.20% | 0.48% | 0.36% | 0.40% |
Retained Earnings | -1.80% | -2.11% | -2.79% | -3.11% | -14.42% |
Treasury Stock & Other | -- | -- | -- | 600.00% | -116.00% |
Total Common Equity | -58.11% | -66.60% | -43.77% | -33.44% | -60.03% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -58.11% | -66.60% | -43.77% | -33.44% | -60.03% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -58.11% | -66.60% | -43.77% | -33.44% | -60.03% |
|